VRCA Insider Trading

Insider Ownership Percentage: 41.50%
Insider Buying (Last 12 Months): $8,942,546.19
Insider Selling (Last 12 Months): $471,200.18

Verrica Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Verrica Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verrica Pharmaceuticals Share Price & Price History

Current Price: $5.68
Price Change: Price Increase of +0.03 (0.53%)
As of 03/28/2024 10:54 AM ET

This chart shows the closing price history over time for VRCA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Verrica Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2023Perceptive Advisors LlcMajor ShareholderBuy126,116$7.08$892,901.286,983,408View SEC Filing Icon  
12/26/2023Perceptive Advisors LlcMajor ShareholderBuy54,652$6.49$354,691.486,777,566View SEC Filing Icon  
12/21/2023Perceptive Advisors LlcMajor ShareholderBuy200,000$6.17$1,234,000.006,472,914View SEC Filing Icon  
12/18/2023Perceptive Advisors LlcMajor ShareholderBuy456,923$5.41$2,471,953.435,995,906View SEC Filing Icon  
12/15/2023Perceptive Advisors LlcMajor ShareholderBuy500,000$5.97$2,985,000.005,538,983View SEC Filing Icon  
11/14/2023Joe BonaccorsoInsiderSell21,580$2.93$63,229.40103,658View SEC Filing Icon  
7/24/2023Christopher G. HayesInsiderSell33,789$4.83$163,200.8781,925View SEC Filing Icon  
7/24/2023Paul B. ManningDirectorBuy200,000$5.02$1,004,000.007,851,128View SEC Filing Icon  
7/24/2023Ted WhiteCEOSell50,677$4.83$244,769.91128,789View SEC Filing Icon  
7/11/2022Christopher G. HayesInsiderBuy7,500$3.40$25,500.0015,714View SEC Filing Icon  
7/5/2022Christopher G. HayesInsiderBuy5,714$2.10$11,999.408,214View SEC Filing Icon  
7/5/2022John A Stalfort IIIDirectorBuy238,095$2.10$499,999.50700,205View SEC Filing Icon  
7/5/2022Perceptive Advisors LlcMajor ShareholderBuy1,428,571$2.10$2,999,999.105,038,983View SEC Filing Icon  
7/5/2022Ted WhiteCEOBuy23,809$2.10$49,998.9029,466View SEC Filing Icon  
12/2/2021Paul B. ManningDirectorBuy30,023$9.45$283,717.35View SEC Filing Icon  
6/4/2021A. Brian DavisCFOBuy5,000$9.89$49,450.0012,900View SEC Filing Icon  
6/4/2021Christopher G. HayesInsiderBuy2,500$9.79$24,475.002,500View SEC Filing Icon  
6/4/2021Ted WhiteCEOBuy4,000$9.95$39,800.0021,966View SEC Filing Icon  
3/25/2021Paul B. ManningDirectorBuy739,830$14.75$10,912,492.50View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Verrica Pharmaceuticals (NASDAQ:VRCA)

42.45% of Verrica Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VRCA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Verrica Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.1,261,101$9.23M0.0%+2.8%2.973%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC7,099,182$51.97M1.2%+40.9%16.879%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP38,546$0.28M0.0%+66.0%0.092%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC28,640$0.21M0.0%+688.5%0.068%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.1,261,101$9.23M0.0%+2.8%2.998%Search for SEC Filing on Google Icon
2/15/2024Bridgeway Capital Management LLC106,750$0.78M0.0%+43.2%0.254%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC3,999,999$29.28M0.4%+35.4%9.510%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.65,305$0.48M0.0%N/A0.155%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp198,881$1.46M0.0%+6.1%0.473%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG24,287$0.18M0.0%+118.3%0.058%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP11,654$85K0.0%-31.3%0.028%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets39,988$0.29M0.0%+210.9%0.095%Search for SEC Filing on Google Icon
2/2/2024Truist Financial Corp10,545$77K0.0%-33.8%0.025%Search for SEC Filing on Google Icon
1/31/2024Kornitzer Capital Management Inc. KS74,251$0.54M0.0%-25.2%0.177%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC180,000$1.32M1.0%+20.0%0.428%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.1,226,858$4.77M0.0%+0.2%2.917%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.15,276$59K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP23,214$90K0.0%-39.2%0.055%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC21,968$85K0.0%N/A0.052%Search for SEC Filing on Google Icon
11/13/2023Stifel Financial Corp20,500$80K0.0%N/A0.049%Search for SEC Filing on Google Icon
11/13/2023FMR LLC1,504,716$5.85M0.0%+29.4%3.578%Search for SEC Filing on Google Icon
11/9/2023Kovitz Investment Group Partners LLC50,125$0.20M0.0%+44.3%0.119%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund9,123$35K0.0%-44.4%0.022%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC18,200$71K0.0%N/A0.043%Search for SEC Filing on Google Icon
10/31/2023Kornitzer Capital Management Inc. KS99,251$0.39M0.0%-23.2%0.236%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System6,944$40K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/16/2023Nuveen Asset Management LLC95,032$0.55M0.0%N/A0.226%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN10,197$59K0.0%+526.4%0.024%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.21,595$0.13M0.0%-69.2%0.051%Search for SEC Filing on Google Icon
8/15/2023Royal Bank of Canada9,711$55K0.0%+129.2%0.023%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP53,930$0.31M0.0%+302.2%0.128%Search for SEC Filing on Google Icon
8/14/2023State Street Corp376,111$2.17M0.0%+455.4%0.894%Search for SEC Filing on Google Icon
8/14/2023MML Investors Services LLC141,550$0.82M0.0%+22.7%0.337%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC95,032$0.55M0.0%N/A0.226%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC159,300$0.92M0.0%+181.9%0.379%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.1,003,380$5.79M0.0%+840.7%2.386%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC388,507$2.24M0.0%+114.8%0.924%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.17,871$0.10M0.0%+1,347.0%0.042%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp189,155$1.09M0.0%+267.9%0.450%Search for SEC Filing on Google Icon
8/10/2023MetLife Investment Management LLC11,190$65K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/10/2023Mirae Asset Global Investments Co. Ltd.47,963$0.28M0.0%N/A0.114%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.55,356$0.32M0.0%N/A0.132%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.6,217$36K0.0%-44.7%0.015%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC6,110$35K0.0%+879.2%0.015%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.10,048$58K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/3/2023SPC Financial Inc.30,000$0.17M0.0%N/A0.072%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp64,038$0.37M0.0%+338.3%0.153%Search for SEC Filing on Google Icon
8/1/2023Truist Financial Corp15,928$92K0.0%+41.0%0.038%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.13,570$78K0.0%N/A0.032%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC133,406$0.87M0.0%+639.0%0.318%Search for SEC Filing on Google Icon
5/16/2023State Street Corp67,716$0.44M0.0%+7.8%0.161%Search for SEC Filing on Google Icon
5/16/2023Squarepoint Ops LLC23,398$0.15M0.0%N/A0.056%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC180,883$1.18M0.0%+11.0%0.431%Search for SEC Filing on Google Icon
5/16/2023Avoro Capital Advisors LLC2,650,000$17.23M0.3%N/A6.316%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC17,357$0.11M0.0%N/A0.041%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP20,900$0.14M0.0%-36.5%0.050%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP47,093$0.31M0.0%-7.3%0.113%Search for SEC Filing on Google Icon
5/15/2023XTX Topco Ltd22,619$0.15M0.0%N/A0.054%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC56,500$0.37M0.0%-63.9%0.135%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.106,668$0.69M0.0%+25.7%0.255%Search for SEC Filing on Google Icon
5/12/2023MML Investors Services LLC115,350$0.75M0.0%+16.1%0.276%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE37,443$0.24M0.0%+84.0%0.089%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP26,464$0.17M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP16,967$0.11M0.0%N/A0.041%Search for SEC Filing on Google Icon
5/11/2023FMR LLC1,360,945$8.85M0.0%-14.8%3.252%Search for SEC Filing on Google Icon
5/11/2023Kovitz Investment Group Partners LLC34,725$0.23M0.0%+15.3%0.083%Search for SEC Filing on Google Icon
5/11/2023Citigroup Inc.11,245$73K0.0%N/A0.027%Search for SEC Filing on Google Icon
5/9/2023Tower Research Capital LLC TRC 7,966$51K0.0%+25.3%0.019%Search for SEC Filing on Google Icon
5/9/2023Bank of New York Mellon Corp14,612$95K0.0%+27.1%0.035%Search for SEC Filing on Google Icon
5/9/2023Manchester Capital Management LLC10,000$65K0.0%N/A0.024%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC16,922$0.11M0.0%N/A0.040%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC29,909$0.19M0.0%N/A0.071%Search for SEC Filing on Google Icon
4/20/2023Miracle Mile Advisors LLC118,221$0.77M0.0%-5.4%0.282%Search for SEC Filing on Google Icon
4/19/2023Legacy Trust18,750$0.12M0.0%N/A0.045%Search for SEC Filing on Google Icon
4/14/2023BML Capital Management LLC150,000$0.98M0.8%-86.5%0.358%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC18,052$50K0.0%N/A0.044%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC205,446$0.57M0.0%+177.4%0.500%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley13,257$36K0.0%-68.7%0.032%Search for SEC Filing on Google Icon
2/14/2023Susquehanna International Group LLP45,285$0.13M0.0%+29.4%0.110%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP50,820$0.14M0.0%+3.9%0.124%Search for SEC Filing on Google Icon
2/13/2023BML Capital Management LLC1,110,605$3.05M2.9%N/A2.703%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC156,374$0.43M0.0%-32.1%0.381%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC162,963$0.45M0.0%+8.5%0.397%Search for SEC Filing on Google Icon
2/10/2023Creative Planning20,018$55K0.0%+35.4%0.049%Search for SEC Filing on Google Icon
2/10/2023Fosun International Ltd129,013$0.36M0.0%-54.3%0.314%Search for SEC Filing on Google Icon
2/8/2023Conning Inc.129,013$0.36M0.0%N/A0.314%Search for SEC Filing on Google Icon
2/7/2023LPL Financial LLC26,000$72K0.0%+18.2%0.063%Search for SEC Filing on Google Icon
1/19/2023Kovitz Investment Group Partners LLC30,125$83K0.0%N/A0.073%Search for SEC Filing on Google Icon
11/15/2022State Street Corp62,816$0.18M0.0%-24.1%0.153%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP12,600$37K0.0%N/A0.031%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP48,893$0.14M0.0%-9.9%0.119%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.279,296$0.82M0.0%+31.9%0.680%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.485,802$1.42M0.0%-35.6%1.182%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC9,422$28K0.0%+685.2%0.023%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC230,300$0.67M0.0%+380.8%0.560%Search for SEC Filing on Google Icon
11/14/2022MML Investors Services LLC89,950$0.26M0.0%+104.9%0.219%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC10,834$32K0.0%-56.1%0.026%Search for SEC Filing on Google Icon
11/3/2022Creative Planning14,781$43K0.0%N/A0.036%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.31,750$61K0.0%+193.9%0.115%Search for SEC Filing on Google Icon
8/16/2022CVI Holdings LLC450,000$0.86M0.1%N/A1.635%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Verrica Pharmaceuticals logo
Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases in the United States. Its product pipeline comprises YCANTH (VP-102), which is in phase III clinical trial for the treatment of common warts; and has completed phase II clinical trial for the treatment of external genital warts. The company also develops VP-315, an oncolytic peptide-based injectable therapy, which is in phase II clinical trial for the treatment of dermatology oncologic conditions which includes basal cell carcinoma; and VP-103, a cantharidin-based product candidate for the treatment of plantar warts and is in phase II clinical trial. In addition, it offers YCANTH for the treatment of molluscum contagiosum. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for dermatological oncology indications, such as non-metastatic melanoma and non-metastatic merkel cell carcinoma. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Read More on Verrica Pharmaceuticals

Today's Range

Now: $5.68
Low: $5.60
High: $5.70

50 Day Range

MA: $5.35
Low: $4.74
High: $5.99

52 Week Range

Now: $5.68
Low: $2.86
High: $7.76

Volume

4,815 shs

Average Volume

150,784 shs

Market Capitalization

$240.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.87

Who are the company insiders with the largest holdings of Verrica Pharmaceuticals?

Verrica Pharmaceuticals' top insider investors include:
  1. Paul B Manning (Director)
  2. Perceptive Advisors Llc (Major Shareholder)
  3. John A Stalfort III (Director)
  4. Ted White (CEO)
  5. Joe Bonaccorso (Insider)
  6. Christopher G Hayes (Insider)
Learn More about top insider investors at Verrica Pharmaceuticals.

Who are the major institutional investors of Verrica Pharmaceuticals?

Verrica Pharmaceuticals' top institutional shareholders include:
  1. Perceptive Advisors LLC — 16.88%
  2. Avoro Capital Advisors LLC — 9.51%
  3. Vanguard Group Inc. — 3.00%
  4. Vanguard Group Inc. — 2.97%
  5. Northern Trust Corp — 0.47%
  6. BML Capital Management LLC — 0.43%
Learn More about top institutional investors of Verrica Pharmaceuticals stock.

Which major investors are selling Verrica Pharmaceuticals stock?

During the last quarter, VRCA stock was sold by these institutional investors:
  1. Kornitzer Capital Management Inc. KS
  2. Citadel Advisors LLC
  3. Truist Financial Corp
  4. Dimensional Fund Advisors LP
  5. Simplex Trading LLC
Within the last year, company insiders that have sold Verrica Pharmaceuticals company stock include:
  1. Paul B Manning (Director)
  2. Perceptive Advisors Llc (Major Shareholder)
  3. John A Stalfort III (Director)
Learn More investors selling Verrica Pharmaceuticals stock.

Which major investors are buying Verrica Pharmaceuticals stock?

Within the previous quarter, VRCA stock was bought by institutional investors including:
  1. Perceptive Advisors LLC
  2. Avoro Capital Advisors LLC
  3. Balyasny Asset Management L.P.
  4. Vanguard Group Inc.
  5. Vanguard Group Inc.
  6. Bridgeway Capital Management LLC
  7. BML Capital Management LLC
  8. BNP Paribas Financial Markets
During the previous year, these company insiders have bought Verrica Pharmaceuticals stock:
  1. Paul B Manning (Director)
  2. Perceptive Advisors Llc (Major Shareholder)
  3. John A Stalfort III (Director)
  4. Ted White (CEO)
  5. Joe Bonaccorso (Insider)
Learn More investors buying Verrica Pharmaceuticals stock.